Shilpa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHILPA, and when can generic versions of SHILPA drugs launch?
SHILPA has fourteen approved drugs.
There are five US patents protecting SHILPA drugs. There are two tentative approvals on SHILPA drugs.
There are fifty-four patent family members on SHILPA drugs in twenty-six countries and fifty supplementary protection certificates in sixteen countries.
Summary for Shilpa
International Patents: | 54 |
US Patents: | 5 |
Tradenames: | 12 |
Ingredients: | 12 |
NDAs: | 14 |
Patent Litigation for Shilpa: | See patent lawsuits for Shilpa |
Drugs and US Patents for Shilpa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 210327-002 | May 16, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Shilpa | IMATINIB MESYLATE | imatinib mesylate | TABLET;ORAL | 208302-001 | Jan 17, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Shilpa | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 210327-003 | May 16, 2019 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Shilpa Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Taiwan | I624274 | ⤷ Sign Up |
Russian Federation | 2015116260 | ⤷ Sign Up |
Mexico | 364948 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Shilpa Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0253738 | C960002 | Netherlands | ⤷ Sign Up | PRODUCT NAME: DOCETAXEL, DESGEWENST IN DE VORM VAN EEN TRIHYDRAAT; REGISTRATION NO/DATE: EU/1/95/002/001 - EU/1/95/002/002 19951127 |
0564409 | C00564409/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: IMATINIB; REGISTRATION NO/DATE: IKS 55807 20010621 |
0432677 | 7/2005 | Austria | ⤷ Sign Up | PRODUCT NAME: PEMETREXED UND DESSEN PHARMAZEUTISCH ANNAHMBAREN SALZE; REGISTRATION NO/DATE: EU/1/04/290/001 20040920 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.